Cubist Pharmaceuticals Inc (NASDAQ:CBST) Investor Alert: Lawsuit Against Takeover Filed
An investor, who currently holds shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), filed a lawsuit in effort to halt the proposed takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share.
View full press release